Health Policy
September 17, 2012 | Feature/Topic
Browse research, insight and analysis on key issues affecting health and health care in the United States.
Industry Regulation
You are now viewing 1 - 7 of 7 results
Sort results by:
Impact of FDA Black Box Advisory on Antipsychotic Medication Use
January 11, 2010 | Journal Article
The 2005 US Food and Drug Administration (FDA) "black box" advisory warning that atypical antipsychotic drugs increased risk of death with elderly patients with dementia led to fewer mentions of the drugs by physicians in the four years after implementation of the drug label requirement.
Limiting the Influence of Pharmaceutical Industry Gifts on Physicians
January 1, 2010 | Journal Article
The medical profession and pharmaceutical industry have fallen short in reducing the influence of gifts on prescription practices through self-regulation. This commentary describes efforts at self-regulation by the pharmaceutical industry and the medical profession.
Policy Tragedy and the Emergence of Regulation
February 24, 2009 | Journal Article
Traditional thinking on regulatory law is that regulations arise in large part from crises. The authors propose a more nuanced view, that crises require reframing to the public and control of the narrative to act as spurs for policy.
Biomarkers Unbound
June 21, 2012 | Journal Article
Biomarkers may prove important in medicine, but controversy about biomarker patents has increased in recent years.
An Empirical Review of Major Legislation Affecting Drug Development
September 1, 2011 | Journal Article
Using market exclusivity to promote pharmaceutical innovation can lead to positive outcomes, but the practice is also characterized by waste and collateral effects.
Pharmaceutical Company Payments to Physicians
March 21, 2007 | Journal Article
This study sets out to determine the accessibility and quality of the data available in two states where payment information is made available to the public, Vermont and Minnesota.